Comparing Ocrevus vs Siponimod
| Ocrevus (ocrelizumab) | Siponimod |
|
|---|
| Ocrevus (ocrelizumab) | Siponimod |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Ocrevus is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate, reducing inflammation in people with MS. After an initial loading dose, it is given by IV infusion every... View more |
Prescription only
Prescribed for Multiple Sclerosis. Siponimod may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||
| More about Ocrevus (ocrelizumab) | More about Siponimod | ||||||||
| Ratings & Reviews | |||||||||
|
Ocrevus has an average rating of 5.4 out of 10 from a total of 177 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 42% reported a negative effect. |
Siponimod has an average rating of 6.8 out of 10 from a total of 9 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Ocrevus side effects |
View all Siponimod side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Ocrevus prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
|
N/A |
Mayzent | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
624 hours |
30 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 434 drugs are known to interact with Ocrevus:
|
A total of 734 drugs are known to interact with Siponimod:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
March 28, 2017 |
March 26, 2019 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Tecfidera
Tecfidera (dimethyl fumarate) is used to treat relapsing forms of multiple sclerosis. Learn about ...
Avonex
Avonex is an interferon used to treat relapsing multiple sclerosis. It is given by injection into a ...
Briumvi
Briumvi is used to treat relapsing forms of multiple sclerosis (MS) in adults, including clinically ...
Betaseron
Betaseron is used to treat relapsing multiple sclerosis (MS). Learn about side effects ...
Rebif
Rebif is used to treat relapsing forms of multiple sclerosis (MS) in adults, including clinically ...
Ocrevus Zunovo
Ocrevus Zunovo (ocrelizumab and hyaluronidase) is a treatment for relapsing forms of multiple ...
Extavia
Extavia is used to treat the relapsing forms of multiple sclerosis. Learn about side effects ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Copaxone
Copaxone is used to treat relapsing forms of multiple sclerosis (MS) in adults (including ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.